Cell Therapy Manufacturing Is Hitting a Scalabilit..

একটি নতুন নিবন্ধ তৈরি করেছেন

1 ভিতরে

Cell Therapy Manufacturing Is Hitting a Scalability Wall And Most Companies Are Unprepared | #market&Minds

Cell Therapy Manufacturing Is Hitting a Scalability Wall And Most Companies Are Unprepared

Cell Therapy Manufacturing Is Hitting a Scalability Wall And Most Companies Are Unprepared

The promise of personalized medicine is colliding with industrial reality. As CAR-T therapies and regenerative treatments move from clinical trials to commercial scale, manufacturers are discovering that manual processing methods cannot support the volume, consistency, or economics require

লাইক

মন্তব্য করুন

শেয়ার করুন